Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Brain Cancer treatment details. Biologic therapy. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States

Survival: 12.6 months
Toxicity Grade: 4
Treatments: Biologic therapy
Country: United States
City/State/Province: Tampa, FL
Hospital: Lee Moffitt Cancer Center and Research Institute
Journal: Link
Date: 10/2012

This phase 2 study involved recurrent malignant glioma patients who were separated into different groups based on the specific type of cancer they had. There were 14 patients with anaplastic astrocytoma in group A who had a median age of 48.5 years and 85.7% were male. Group B consisted of 16 glioblastoma patients with a median age of 57.5 years and 62.5% were male.

Patients in groups A and B were treated with the biologic therapy agent sunitinib, which is a tyrosine kinase inhibitor that interferes with cancer cell growth.

There was one grade 5 adverse event reported for group A, which was reported as death due to disease progression. Grade 4 neutropenia and grade 3 fatigue and hand-foot syndrome were also reported.

The most severe toxicities reported in group B were of grade 4 and included neutropenia and thrombocytopenia. Grade 3 fatigue was also reported.

The median overall survival times for groups A and B were 12.1 and 12.6 months, respectively.

This study was supported by Pfizer, Inc.

Correspondence: Dr. Edward Pan; email:

E-mail to a Friend Email Physician More Information